<scp>First‐in‐human</scp> study of <scp>JNJ</scp>‐63709178, a <scp>CD123</scp>/<scp>CD3</scp> targeting antibody, in relapsed/refractory acute myeloid leukemia

Michael Boyiadzis, Juan Manuel Alonso‐Domínguez, Nikki Daskalakis et al.|Clinical and Translational Science|2022

Cited by 35